These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10505492)

  • 1. Obesity and hypertension.
    Mikhail N; Golub MS; Tuck ML
    Prog Cardiovasc Dis; 1999; 42(1):39-58. PubMed ID: 10505492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
    Reisin E; Jack AV
    Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms in obesity-related hypertension: role of insulin and catecholamines.
    Krieger DR; Landsberg L
    Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of the obesity-related arterial hypertension.
    Kolanowski J
    Acta Clin Belg Suppl; 1992; 14():18-25. PubMed ID: 1604957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
    Ernsberger P; Koletsky RJ; Collins LA; Bedol D
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and hypertension: epidemiology, mechanisms, treatment.
    Berchtold P; Sims EA; Horton ES; Berger M
    Biomed Pharmacother; 1983; 37(6):251-8. PubMed ID: 6367845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertension in obesity].
    Scholze J; Sharma AM
    Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and Clinical Aspects of Obesity Related Hypertension.
    Mikhail N; Tuck ML
    J Clin Hypertens (Greenwich); 2000 Jan; 2(1):41-45. PubMed ID: 11416625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and obesity.
    Dustan HP
    Prim Care; 1991 Sep; 18(3):495-507. PubMed ID: 1946785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and hypertension.
    Hsueh WA; Buchanan TA
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):405-27. PubMed ID: 8070430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and obesity: epidemiology, mechanisms and clinical approach.
    Becton LJ; Shatat IF; Flynn JT
    Indian J Pediatr; 2012 Aug; 79(8):1056-61. PubMed ID: 22664863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).
    Landsberg L
    J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sympathetic nervous system and neuropeptides in obesity hypertension.
    Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S
    Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.
    Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N
    J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, hypertension, and sympathetic nervous system activity.
    Corry DB; Tuck ML
    Curr Hypertens Rep; 1999; 1(2):119-26. PubMed ID: 10981052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.